AGA Quality Measures for Preventative Strategies in patients with IBD

Release Date: November 5, 2014
Expiration Date: November 5, 2015

Target Audience: The intended audience for this activity is gastroenterologists and other healthcare professionals involved in the treatment of patients with IBD.

Statement of Need/Program Overview/Goal: 
Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) is one of the most prevalent gastrointestinal diseases in the United States. Despite effective therapies that aid patients to achieve disease control and even remission, many individuals continue to receive care that is not recommended by practice guidelines. Agents used in the management of IBD can have serious overall consequences, such as increased infection risk and deleterious effects on bone health. In this activity, participants will learn to mitigate iatrogenic injury in IBD patients by implementing quality improvement measures aimed at administering appropriate vaccinations and the appropriate use of corticosteroid-sparing therapies. In addition, smoking cessation techniques and relevant counseling strategies will also be discussed.

Educational (Learning) Objectives:

• Improve preventive care in the management of inflammatory bowel disease by optimizing corticosteroid sparing therapy.
• Immunize patients with inflammatory bowel disease against influenza and pneumococcal disease to reduce complications.
• Screen patients with inflammatory bowel disease for tobacco use and implement effective cessation interventions.

Provider Statement: This continuing medical education activity is provided by AGA Institute.  
Educational Partner: Vindico Medical Education

Accreditation Statements:
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The AGA Institute designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Faculty Information:
Gary R. Lichtenstein, MD
Professor of Medicine
Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
GI Administration Offices
Philadelphia, PA

Planning Committee and Faculty members report the following relationship(s):

Consulting Fee: Abbott Corporation/ Abbvie, Alaven, Elan, Ferring, Hospira, Janssen Orthobiotech, Luitpold/ American Regent, Millenium Pharmaceuticals, Ono Pharmaceuticals, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Salix Pharmaceuticals, Santarus, Shire Pharmaceuticals, Takeda, UCB, Warner Chilcotte

Contracted Research: Bristol-Myers Squibb, Ferring, Janssen Orthobiotech, Prometheus Laboratories, Inc., Salix Pharmaceuticals, Santarus, Shire Pharmaceuticals, UCB, Warner Chilcotte

Grant: Funding to the University of Pennsylvania for IBD fellow education- Warner Chilcotte

External Reviewer reports the following relationship(s):
Ronald A. Codario, MD, FACP, RPVI, FNLA, CCMEP
No relevant financial relationships to disclose

The AGA Institute and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Method of Participation (Instructions):
 To receive a statement of credit, you must:
- Review the full content of the program.
- Successfully complete the post-test (67% or higher)
- You will have unlimited opportunities to successfully complete the program.

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form.

Fee: none

Commercial Support: This activity is supported by an educational grant from AbbVie.  

Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of The AGA Institute and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of The AGA Institute and Vindico Medical Education. Neither The AGA Institute and Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Viewing Requirements: 
Internet Explorer 7 or greater
Firefox (Latest Version)
Google Chrome
Safari (Latest Version)
Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
Mac OS 10.4